Mast Cell Activation Syndrome (MCAS)
Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells—specialised immune cells found throughout the body—release inflammatory chemicals too easily or too intensely. These episodes can affect multiple body systems at once, causing symptoms such as flushing, itching, abdominal pain, diarrhoea, dizziness, rapid heartbeat, breathing difficulties and, in some cases, severe allergic-like reactions.
Although awareness of MCAS has increased considerably in recent years, it remains one of the most debated areas of clinical immunology. At Rowan Health, we follow the internationally validated diagnostic criteria and provide an evidence-informed assessment that aims to identify genuine mast cell disorders while carefully investigating other conditions that can produce similar symptoms.
This information is intended for educational purposes and should not replace professional medical advice. If you have new, severe or worsening symptoms, always seek advice from your GP or specialist healthcare team.
KEY FACTS
✔ Medical name
Mast Cell Activation Syndrome (MCAS)
✔ What it affects
The immune system and multiple organs, including the skin, digestive tract, airways, cardiovascular system and nervous system.
✔ Common symptoms
Flushing, itching, hives, swelling, abdominal pain, diarrhoea, nausea, dizziness, rapid heartbeat, wheezing, nasal congestion and, in severe cases, anaphylaxis.
✔ Who can be affected?
MCAS most commonly presents in adults and is reported more frequently in women, although it can affect people of any age.
✔ How is it diagnosed?
Diagnosis requires three internationally accepted criteria:
Recurrent episodes involving two or more organ systems.
Objective laboratory evidence of mast cell activation.
Clear improvement with mast-cell-targeted treatment.
✔ Can it be treated?
Many people achieve good symptom control through trigger identification, medication and personalised long-term management.
✔ Associated conditions
Hypermobile Ehlers-Danlos Syndrome (hEDS)
Hypermobility Spectrum Disorder (HSD)
Postural Orthostatic Tachycardia Syndrome (POTS)
Chronic Fatigue Syndrome / ME
Chronic spontaneous urticaria
Allergic disease
✔ When should I seek urgent medical advice?
Difficulty breathing, throat swelling, collapse or severe allergic-type reactions require immediate emergency treatment.
UNDERSTANDING THE CONDITION
Mast cells are an important part of your immune system.
They are found throughout the body, particularly in the skin, digestive tract, airways and around blood vessels and nerves. Their normal role is to detect potential threats—such as infections, allergens or injury—and rapidly release chemical messengers that help coordinate the body's defence response.
These substances include histamine, tryptase, prostaglandins and leukotrienes, each of which has different effects on blood vessels, smooth muscle and immune cells.
In Mast Cell Activation Syndrome, these cells become over-responsive.
Instead of releasing their chemical mediators only when genuinely needed, they may react excessively or in response to triggers that would not normally provoke an immune response. The result is a series of recurrent episodes that can affect several organs simultaneously and resemble allergic reactions, even when no conventional allergy can be identified.
Unlike mastocytosis, MCAS does not usually involve an excessive number of mast cells. Instead, the existing mast cells are unusually active.
Similarly, MCAS is different from a typical food allergy. Food allergies involve a specific immune response to an allergen, whereas MCAS may be triggered by many different factors and episodes are not always predictable.
Because mast cells are present throughout the body, symptoms can vary considerably between individuals. Some people mainly experience digestive symptoms, while others develop flushing, dizziness, breathing difficulties or widespread reactions involving several body systems.
Understanding this wide range of presentations is one of the reasons why diagnosing MCAS requires a careful and systematic assessment rather than relying on symptoms alone.
COMMON SYMPTOMS
Symptoms usually occur in episodes, although some people experience persistent symptoms between flare-ups.
Because mast cells are found throughout the body, almost any organ system may be affected.
Common symptoms include:
Skin
Flushing
Itching
Hives (urticaria)
Angioedema (swelling)
Redness
Burning skin sensations
Digestive System
Abdominal pain
Cramping
Diarrhoea
Nausea
Vomiting
Bloating
Cardiovascular System
Rapid heartbeat
Dizziness
Light-headedness
Low blood pressure
Feeling faint
Collapse
Respiratory System
Wheezing
Shortness of breath
Nasal congestion
Throat tightness
Stridor (rare)
Nervous System
Some people also report:
Headaches
Difficulty concentrating ("brain fog")
Fatigue
Feeling unwell after episodes
Although these symptoms are commonly described by patients, they are not themselves sufficient to diagnose MCAS, as many other conditions can produce similar symptoms. Diagnosis depends on the combination of symptom pattern, laboratory evidence and treatment response.
CAUSES, MECHANISMS AND DIAGNOSIS
Why Does It Happen?
One of the easiest ways to understand Mast Cell Activation Syndrome is to think of mast cells as the body's early warning system.
Mast cells are specialised immune cells located throughout the body, particularly where we come into contact with the outside world—within the skin, airways, digestive tract and around blood vessels and nerves. Their job is to recognise potential threats and rapidly coordinate the body's first line of defence.
When functioning normally, mast cells help protect us from infections, parasites, toxins and injury.
When activated, they release a wide range of chemical messengers—including histamine, tryptase, prostaglandins and leukotrienes—which increase blood flow, recruit other immune cells and help the body respond quickly to danger.
In most people, this response is tightly controlled.
In MCAS, however, the alarm system becomes too sensitive.
An Oversensitive Smoke Alarm
Imagine a smoke alarm installed in your home.
Normally, it sounds only when there is a genuine fire.
If the sensitivity becomes too high, however, it may start ringing when someone burns toast, opens the oven or even takes a hot shower.
The alarm itself is not broken.
It is simply reacting far more easily than it should.
Mast cells behave in a similar way.
Instead of responding only to genuine threats, they may release inflammatory chemicals after exposure to heat, exercise, certain foods, stress, medications or other triggers that would not normally cause a significant immune response.
Why So Many Different Symptoms?
Because mast cells are distributed throughout the body, the chemicals they release can affect many different organs at the same time.
For example:
Mediator released | Possible effects |
Histamine | Flushing, itching, hives, stomach acid production, diarrhoea |
Tryptase | Marker of mast cell activation, inflammation |
Prostaglandins | Flushing, abdominal symptoms, bronchoconstriction |
Leukotrienes | Airway narrowing, wheezing, gastrointestinal symptoms |
Each episode may therefore involve several body systems simultaneously, explaining why someone might experience flushing, abdominal cramps, dizziness and wheezing during the same attack.
Why Symptoms Can Vary So Much
No two people with MCAS experience exactly the same pattern.
Some predominantly develop skin symptoms.
Others experience digestive problems.
Some mainly have cardiovascular symptoms such as dizziness, palpitations or fainting.
The pattern may also change over time, making the condition difficult to recognise.
Episodes can last from minutes to several hours and may vary considerably in severity.
Why Is MCAS So Difficult to Recognise?
One reason MCAS is challenging to diagnose is that many of its symptoms are non-specific.
Flushing, abdominal pain, diarrhoea, fatigue, dizziness and palpitations may also occur in numerous other conditions.
Furthermore, many patients are completely well between episodes.
For this reason, diagnosis cannot rely on symptoms alone.
Instead, clinicians look for a combination of:
recurrent episodes affecting multiple organ systems
objective laboratory evidence that mast cells have been activated
clear improvement with treatments that specifically target mast cells or their chemical mediators.
MCAS Is Not the Same as an Allergy
Although MCAS often resembles an allergic reaction, the two conditions are not the same.
A typical allergy occurs when the immune system reacts to a specific allergen through an IgE-mediated mechanism.
In MCAS, mast cells may be activated through several different pathways, including non-allergic mechanisms such as physical stimuli (heat, cold, pressure or exercise), certain medications or psychological stress. This explains why many people react to multiple, seemingly unrelated triggers rather than a single allergen.
Understanding the Condition
For many people, simply understanding how mast cells work is an important step towards making sense of their symptoms.
Knowing that episodes reflect genuine changes in immune cell activity—not anxiety, imagination or "overreacting"—can help explain why symptoms fluctuate so widely and why identifying individual triggers is an important part of long-term management.
Common Triggers
Although triggers vary from person to person, certain factors are reported more frequently.
These include:
Physical triggers
Heat
Cold
Rapid temperature changes
Exercise
Friction or pressure on the skin
Foods and drinks
Alcohol
Certain foods
Food additives (in some individuals)
Medications
Some medicines may trigger mast cell activation in susceptible people, including:
Certain opioids
Some non-steroidal anti-inflammatory drugs (NSAIDs)
Some antibiotics
Radiological contrast media
Medication reactions should always be assessed individually and should never lead to stopping prescribed medicines without medical advice.
Emotional and physiological triggers
Emotional stress
Acute illness
Infection
Hormonal changes
Menstrual cycle
Not every person with MCAS reacts to the same triggers. Keeping a structured symptom and trigger diary is often one of the most useful ways of identifying individual patterns over time and forms part of the Rowan Health assessment pathway.
The Mast Cell–Nervous System Connection
For many years, mast cells were viewed simply as immune cells involved in allergies.
Research now shows that they also communicate closely with the nervous system.
Mast cells are found alongside nerves throughout the skin, digestive tract, lungs and blood vessels. These cells and nearby nerve fibres constantly exchange chemical signals, allowing the immune and nervous systems to work together in responding to changes inside and outside the body.
This close relationship helps explain why MCAS symptoms can affect so many different parts of the body and why they often fluctuate over time.
A Two-Way Conversation
The relationship between mast cells and nerves works in both directions.
When mast cells become activated, they release inflammatory mediators such as histamine, prostaglandins and leukotrienes. These substances can stimulate nearby nerves, contributing to symptoms including:
Itching
Burning sensations
Abdominal cramping
Headaches
Flushing
Changes in blood vessel tone
Altered bowel function
At the same time, the nervous system can influence mast cell activity. Certain neuropeptides and stress-related signalling molecules can increase the likelihood that mast cells will release their mediators. This does not mean that symptoms are "caused by stress"; rather, it reflects the normal biological communication between the nervous and immune systems.
Why Symptoms Can Fluctuate
Many people with MCAS notice that symptoms seem unpredictable.
One week they may feel relatively well, while the next they experience repeated flare-ups.
This variability often reflects the combined influence of several factors rather than a single trigger.
For example, a person may tolerate a particular food on most days but react when several other factors are present, such as:
Poor sleep
A viral infection
Emotional stress
Hormonal changes
Physical exertion
Exposure to heat
Each factor may add to the overall burden on the immune system until a threshold is reached and mast cells become activated.
Understanding these patterns can help explain why reactions sometimes seem inconsistent and why keeping a symptom diary is often more informative than focusing on a single suspected trigger.
Why Do Some Conditions Overlap?
Researchers have observed that MCAS frequently occurs alongside other chronic conditions, including:
Hypermobile Ehlers-Danlos Syndrome (hEDS)
Hypermobility Spectrum Disorder (HSD)
Postural Orthostatic Tachycardia Syndrome (POTS)
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
The exact relationship between these conditions is still being investigated, and current evidence does not show that one necessarily causes another. However, recognising these associations is clinically important because symptoms may overlap, and more than one condition may contribute to a person's health.
Looking at the Whole Person
Because the immune, nervous, hormonal and cardiovascular systems constantly interact, understanding MCAS involves more than simply identifying individual allergic-type reactions.
A comprehensive assessment considers:
The pattern and timing of symptoms.
Possible triggers.
Laboratory evidence of mast cell activation.
Co-existing medical conditions.
The impact on everyday life.
Current medications and previous responses to treatment.
This broader perspective helps ensure that management is based on the most likely underlying causes rather than focusing on isolated symptoms alone.
A Note About Integrative Care
At Rowan Health, our role is to complement—not replace—conventional medical care.
I
f your assessment suggests MCAS, we work alongside your GP, allergist or immunologist to support your overall health and quality of life. Where appropriate, we also assess associated conditions such as hypermobility, autonomic dysfunction, persistent fatigue or chronic pain, helping to develop a coordinated and personalised management plan.
Depending on your individual needs, support may combine education, lifestyle strategies, rehabilitation, laboratory-supported assessment and selected evidence-informed integrative approaches alongside your prescribed medical treatment. Our aim is to improve function, reduce the impact of symptoms and help you manage your condition with greater confidence.
How It Is Diagnosed
Although awareness of Mast Cell Activation Syndrome has increased rapidly over recent years, it remains one of the most debated diagnoses in clinical immunology.
Many conditions can produce symptoms similar to MCAS, and there is currently no single test that confirms the diagnosis.
Instead, doctors must bring together your clinical history, laboratory results and response to treatment before determining whether the internationally accepted diagnostic criteria are met.
Adding to the confusion, you may come across different explanations of MCAS online. This is because two diagnostic frameworks currently circulate under the same name, although only one has been internationally validated.
Two Different Diagnostic Frameworks
One reason people receive conflicting information is that two different approaches to diagnosing MCAS exist.
At Rowan Health, we follow the internationally validated consensus criteria, which are supported by major expert organisations and are designed to distinguish genuine mast cell disorders from other conditions with similar symptoms.
A broader, more permissive framework has also been proposed and is widely discussed online. This alternative approach accepts a wider range of chronic symptoms and does not always require the same laboratory evidence. However, it has not yet been validated to the same standard, and current research suggests it may include many people whose symptoms have a different underlying cause.
This Does Not Mean Your Symptoms Are Not Real
It is important to understand that not meeting the current diagnostic criteria for MCAS does not mean your symptoms are imagined or unimportant.
Many people referred with suspected MCAS experience genuine, often disabling symptoms.
The purpose of careful assessment is not to dismiss these symptoms but to identify their most likely cause so that appropriate treatment can be offered.
Sometimes the answer is MCAS.
Sometimes another condition provides a better explanation.
In either situation, the goal is to reach an accurate diagnosis rather than simply applying a label. This evidence-first approach is a core principle of the Rowan Health programme.
How Is MCAS Diagnosed?
The internationally accepted diagnostic framework requires all three of the following criteria to be satisfied.
1. Typical Episodes
Symptoms must occur in recurrent episodes involving two or more organ systems at the same time.
For example:
Flushing together with diarrhoea
Rapid heartbeat with dizziness and wheezing
Hives associated with abdominal pain
This pattern reflects widespread release of mast cell mediators throughout the body rather than symptoms affecting only a single organ.
2. Laboratory Evidence
During one of these episodes, blood tests should demonstrate objective evidence of mast cell activation.
The preferred test is serum tryptase.
To be diagnostically useful:
a baseline (resting) tryptase level is measured when you are well
a second sample is taken during an acute episode, ideally within four hours of symptom onset
the episode result is compared with the baseline using the internationally accepted 20% + 2 ng/mL formula.
Although additional mediator tests may sometimes support assessment, they should not be used on their own to diagnose MCAS because they are influenced by factors such as diet, medications and sample collection techniques.
3. Response to Treatment
The third criterion is a documented improvement after treatment directed at mast cells or the chemicals they release.
Examples include:
Antihistamines
Mast cell stabilisers
Anti-leukotriene medications
Improvement should be recorded objectively rather than relying solely on memory, which is why structured symptom monitoring forms part of the Rowan Health clinical pathway.
Why Timing Matters
One of the most common reasons the diagnosis is missed is that blood samples are collected too late.
Tryptase rises for only a limited period after mast cell activation.
For this reason, blood should ideally be taken within four hours of symptoms starting.
If samples are obtained later, results may appear normal even in someone who has experienced genuine mast cell activation.
To make this process easier, Rowan Health provides patients undergoing investigation with clear instructions on when to seek testing during an episode and encourages the use of a symptom and trigger diary to improve diagnostic accuracy.
Looking Beyond MCAS
Because many conditions can resemble MCAS, assessment also aims to identify other possible explanations for your symptoms.
Depending on your presentation, this may include investigations for:
IgE-mediated allergy
Systemic mastocytosis
Hereditary alpha-tryptasaemia (HαT)
Chronic spontaneous urticaria
Histamine intolerance
Postural Orthostatic Tachycardia Syndrome (POTS)
Carcinoid syndrome
Phaeochromocytoma
Other conditions causing recurrent flushing, gastrointestinal symptoms or dizziness.
Similarly, because MCAS frequently overlaps with other chronic conditions, your assessment may include screening for:
Hypermobility Spectrum Disorder (HSD)
Hypermobile Ehlers-Danlos Syndrome (hEDS)
Postural Orthostatic Tachycardia Syndrome (POTS)
ME/CFS
Chronic pain syndromes
Where appropriate, these conditions are assessed using their own dedicated Rowan Health clinical pathways to provide an integrated, personalised management plan.
HOW IS IT USUALLY MANAGED?
Management depends on the diagnosis, symptom severity, underlying mechanisms and each person's individual circumstances.
There is currently no cure for Mast Cell Activation Syndrome. The aim of treatment is to reduce the frequency and severity of episodes, improve quality of life and minimise the risk of severe reactions.
Management is highly individualised because triggers, symptoms and underlying mechanisms vary considerably between people.
Current treatment usually combines trigger identification, medication and regular review, with escalation only when necessary. Although several medications are widely used, it is important to recognise that much of the evidence comes from studies of mastocytosis, chronic urticaria and anaphylaxis rather than large clinical trials conducted specifically in MCAS.
Identifying and Avoiding Triggers
The first step in management is understanding what provokes your symptoms.
Triggers vary greatly between individuals and may include:
Heat or cold
Exercise
Emotional stress
Certain foods or alcohol
Infections
Hormonal changes
Specific medications
Rather than recommending broad or unnecessary restrictions, current guidance encourages a structured symptom and trigger diary to identify your own pattern of reactions. This allows management to be tailored to your circumstances while reducing the risk of unnecessarily restrictive lifestyles.
Antihistamines
Histamine is one of the main chemicals released by activated mast cells.
Many people benefit from medications that block histamine receptors.
Depending on your symptoms, your specialist may recommend:
H1 antihistamines for skin, nasal or respiratory symptoms.
H2 antihistamines for gastrointestinal symptoms and stomach acid production.
The most appropriate medication and dose should always be discussed with your healthcare professional.
Mast Cell Stabilisers
Some medications aim to reduce the tendency of mast cells to release their inflammatory mediators.
These treatments may be considered when symptoms remain troublesome despite antihistamines or where gastrointestinal symptoms are particularly prominent.
Leukotriene Modifiers
Leukotrienes are inflammatory chemicals released alongside histamine.
In selected patients, medications targeting leukotrienes may reduce respiratory or gastrointestinal symptoms and form part of a stepwise treatment approach.
Emergency Management
Some people with MCAS experience severe systemic reactions.
Where there is a history of anaphylaxis or other serious episodes, an individual emergency action plan may be recommended.
For patients prescribed an adrenaline auto-injector, appropriate training in its use is an essential part of ongoing care.
Looking After Your Overall Health
Although medication plays an important role, successful long-term management often involves much more than treating acute episodes.
Many people benefit from:
Maintaining regular sleep patterns.
Managing stress where possible.
Identifying individual triggers.
Reviewing medications before surgery or medical procedures.
Treating associated conditions such as allergies, asthma or eczema.
Managing these factors can reduce the overall burden on the immune system and improve long-term symptom control.
Monitoring Progress
Because symptoms often fluctuate over time, regular review is important.
Monitoring may include:
Frequency of episodes.
Severity of reactions.
Number of body systems involved.
Response to medication.
New triggers.
Review of emergency plans.
Assessment for associated conditions such as hypermobility, POTS, chronic fatigue or chronic pain.
Regular reassessment is particularly important because scientific understanding of MCAS continues to evolve, and diagnosis may need to be reviewed if new evidence or alternative explanations emerge.
LIVING WELL WITH THE CONDITION
Impact on Daily Life
Living with MCAS can be unpredictable.
Many people find that symptoms fluctuate from day to day, making it difficult to plan work, travel, family activities or social events. Episodes may appear without warning or occur after exposure to triggers that are difficult to avoid completely.
This uncertainty can be frustrating, particularly before a diagnosis has been established. Because symptoms often affect multiple body systems and resemble many other conditions, some people spend years seeking an explanation before receiving appropriate assessment.
Learning to recognise your own pattern of symptoms is often one of the most valuable aspects of long-term management. Keeping a symptom and trigger diary, understanding how to respond to flare-ups and knowing when emergency treatment is required can help improve confidence and reduce anxiety about future episodes.
For many people, successful management involves finding the right combination of medication, trigger management, education and regular follow-up. Although symptoms may not disappear completely, many individuals achieve substantial improvements in symptom control, daily functioning and quality of life through a personalised management plan.
HOW ROWAN HEALTH SUPPORTS YOU
At Rowan Health, we provide an evidence-informed assessment to determine whether your symptoms meet the internationally validated criteria for MCAS while also investigating other conditions that can produce similar symptoms.
Following a comprehensive evaluation, we develop a personalised care plan tailored to your diagnosis, symptom pattern and associated conditions. Our aim is to improve symptom control, reduce the impact of flare-ups and support your long-term health alongside your conventional medical care.
When to Seek Medical Advice
Although many episodes of MCAS are mild to moderate, some reactions can become life-threatening and require immediate medical attention.
Call 999 immediately if you experience:
Difficulty breathing or severe wheezing.
Swelling of the tongue or throat.
Difficulty swallowing.
Sudden collapse or loss of consciousness.
Severe dizziness associated with low blood pressure.
Persistent chest tightness with breathing difficulty.
Symptoms of anaphylaxis following food, medication, an insect sting or another trigger.
If you have been prescribed an adrenaline auto-injector (such as an EpiPen®), use it immediately according to your emergency action plan before calling for emergency assistance.
Urgent specialist assessment is also recommended if investigations identify:
Persistently elevated baseline tryptase.
Unexplained skin lesions suggestive of mastocytosis.
Fragility fractures or unexplained osteoporosis.
Unexplained weight loss.
Night sweats.
Enlarged lymph nodes.
If your symptoms are severe, rapidly worsening or causing immediate concern, contact NHS 24 on 111. In a medical emergency, call 999 or attend your nearest Accident & Emergency department.
FAQs
Is MCAS the same as an allergy?
No.
Although MCAS can resemble an allergic reaction, they are different conditions.
Food allergies involve a specific immune response to a particular allergen, whereas MCAS involves inappropriate activation of mast cells that may occur through several different mechanisms and multiple triggers.
Is MCAS the same as histamine intolerance?
No.
Histamine intolerance is thought to result from reduced breakdown of dietary histamine rather than abnormal mast cell activation.
Although symptoms may overlap, they are considered different conditions and require different assessment and management.
Why have I read different information online?
Because two different diagnostic frameworks are currently discussed.
At Rowan Health, we follow the internationally accepted consensus criteria, as these are supported by the strongest available scientific evidence.
Can blood tests be normal?
Yes.
If blood samples are taken too late after an episode, tryptase levels may have already returned to baseline.
This is why correct timing of blood sampling is so important during assessment.
Can MCAS be cured?
There is currently no cure.
However, many people achieve good symptom control by identifying triggers, using appropriate medication and following an individualised management plan.
Why do symptoms affect so many different organs?
Mast cells are found throughout the body.
When activated, they release inflammatory chemicals into many tissues simultaneously, explaining why skin, digestive, cardiovascular and respiratory symptoms often occur together.
Is MCAS linked with other conditions?
Yes.
MCAS is frequently reported alongside:
Hypermobile Ehlers-Danlos Syndrome (hEDS)
Hypermobility Spectrum Disorder (HSD)
Postural Orthostatic Tachycardia Syndrome (POTS)
Chronic Fatigue Syndrome / ME
Although the reasons for these associations are still being investigated, recognising them can help clinicians develop a more comprehensive management plan.
How can Rowan Health help?
Our assessment follows the internationally validated diagnostic criteria while recognising that many conditions can mimic MCAS.
Where appropriate, we also assess associated conditions such as hypermobility, POTS, chronic fatigue and chronic pain, allowing us to develop an integrated, personalised care plan.
Sources & references
Valent P, Akin C, et al. Using the Right Criteria for MCAS. Journal of Allergy and Clinical Immunology: In Practice. 2019.
Valent P, Akin C, et al. Updated Diagnostic Criteria and Classification of Mast Cell Activation Syndromes. Journal of Allergy and Clinical Immunology. 2022.
Akin C. Mast Cell Activation Syndromes. Journal of Allergy and Clinical Immunology. 2017.
Castells M, Butterfield JH. Mast Cell Activation Syndrome and Mastocytosis. Journal of Allergy and Clinical Immunology: In Practice.
European Competence Network on Mastocytosis (ECNM). Classification and Diagnostic Guidance.
AAAAI (American Academy of Allergy, Asthma & Immunology). Mast Cell Disorders.
The Mast Cell Disease Society. Clinical Information and Patient Resources.
Clinical Review
Clinical content reviewed by
Rowan health
Last reviewed:
31 July 2026
Related Resources
Related Conditions
Postural Orthostatic Tachycardia Syndrome (POTS) >
Hypermobile Ehlers-Danlos Syndrome (hEDS) >
Hypermobility Spectrum Disorder (HSD) >
Chronic Fatigue Syndrome / ME >
Histamine Intolerance (coming soon)
Chronic & Complex Conditions Hub >
Related Symptoms
Flushing (coming soon)
Urticaria (coming soon)
Chronic Diarrhoea (coming soon)
Dizziness (coming soon)
Brain Fog (coming soon)
Fatigue (coming soon)
Food Sensitivities (coming soon)
Related Services
If you found this information helpful, you may wish to share it with a family member, friend or someone else who is going through cancer treatment.Better understanding helps people feel more informed and prepared.
Share this page
Would You Like Personalised Support?
At Rowan Health, we provide an evidence-informed assessment to understand whether mast cell activation may be contributing to your symptoms and to identify any associated conditions that may require further investigation.
Following a comprehensive evaluation, we develop a personalised care plan tailored to your diagnosis, symptom pattern and individual needs. Our aim is to improve symptom control, reduce the impact of flare-ups and support your long-term health alongside your conventional medical care.